Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years or older with a diagnosis of chronic intermediate uveitis in at least one eye~Exclusion Criteria:~* Uncontrolled systemic disease~* Any active ocular infections

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Dexamethasone 350 µg
- 2 (Type: ACTIVE_COMPARATOR): Dexamethasone 700 µg
- 3 (Type: SHAM_COMPARATOR): Sham

Based on this trial design, predict the completion outcome and termination type (if applicable).